T
Thomas F. Lüscher
Researcher at University of Zurich
Publications - 1613
Citations - 88517
Thomas F. Lüscher is an academic researcher from University of Zurich. The author has contributed to research in topics: Endothelium & Myocardial infarction. The author has an hindex of 134, co-authored 1560 publications receiving 79034 citations. Previous affiliations of Thomas F. Lüscher include University of Texas Southwestern Medical Center & Durham University.
Papers
More filters
Journal Article
Problem cases in renovascular hypertension.
Thomas F. Lüscher,H. Vetter,W. Tenschert,Greminger P,G. Pouliadis,Ulrich Kuhlmann,Reutter F,Tuma J,Walter Siegenthaler,Wilhelm Vetter +9 more
TL;DR: In complex forms of renovascular hypertension, antihypertensive treatment may be a potent therapeutic alternative if surgery and/or transluminal dilatation can not be performed or seem to have too high a risk.
Journal ArticleDOI
Novel Insights into Vascular Repair Mechanisms
TL;DR: A better understanding of the mechanisms limiting vascular repair in patients with cardiovascular disease may provide novel opportunities for therapeutic interventions aiming to promote the maintenance of vascular integrity.
Journal ArticleDOI
Carnitine — from cellular mechanisms to potential clinical applications in heart disease
TL;DR: This review deals with cellular metabolic actions of carnitine and its potential role as a drug investigated in a number of clinical settings, and the involvement in major metabolic pathways potentially relevant to clinical benefit.
Journal ArticleDOI
Data Sharing: A New Editorial Initiative of the International Committee of Medical Journal Editors. Implications for the Editors´ Network
Fernando Alfonso,Karlen Adamyan,Jean Yves Artigou,Michael Aschermann,Michael Boehm,Alfonso Buendía,Pao-Hsien Chu,Ariel Cohen,Livio Dei Cas,Mirza Dilic,Anton Doubell,Darío Echeverri,Nuray Enç,Ignacio Ferreira-González,Krzysztof J. Filipiak,Andreas J. Flammer,Eckart Fleck,Plamen Gatzov,Carmen Ginghina,Lino Gonçalves,Habib Haouala,Mahmoud Hassanein,Gerd Heusch,Kurt Huber,Ivan Hulín,Mario Ivanuša,Rungroj Krittayaphong,Chu-Pak Lau,Germanas Marinskis,François Mach,Luiz Felipe P. Moreira,Tuomo Nieminen,Latifa Oukerraj,Stefan Perings,Luc Pierard,Tatjana S. Potpara,Walter Reyes-Caorsi,Se-Joong Rim,Olaf Rødevand,Georges Saade,Mikael Sander,Evgeny Shlyakhto,Bilgin Timuralp,Dimitris Tousoulis,Dilek Ural,Jan J. Piek,Albert Varga,Thomas F. Lüscher +47 more
TL;DR: A new editorial initiative to foster sharing of clinical trial data was launched and this review discusses this novel initiative with the aim of increasing awareness among readers, investigators, authors and editors belonging to the Editors´ Network of the European Society of Cardiology.
Journal ArticleDOI
Ticagrelor, but not clopidogrel active metabolite, displays antithrombotic properties in the left atrial endocardium.
Martin F Reiner,Alexander Breitenstein,Alexander Breitenstein,Erik W. Holy,Martina Glanzmann,Heidi Amstalden,Simon F. Stämpfli,Nicole R. Bonetti,Volkmar Falk,Stephan Keller,Gianluigi Savarese,Stefano Benussi,Francesco Maisano,Thomas F. Lüscher,Jürg H. Beer,Jan Steffel,Giovanni G. Camici +16 more
TL;DR: Ticagrelor, but not CAM, reduces expression and activity of TF and PAI-1 in LAA endocardial cells isolated from patients with AF, indicating possible local antithrombotic effects and may contribute to a reduction in thromboembolic complications in patients withAF.